Markets:

Overview

News

Currencies

International

Treasuries

Verrica Pharmaceuticals Inc. - Common Stock (NQ:VRCA)

6.060 +0.160 (+2.71%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Verrica Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

VRCA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc.

June 06, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

NASDAQ:VRCA Shareholder Notice: Investigation over Potential Securities Laws Violations by Verrica Pharmaceuticals Inc. ↗

June 06, 2022

San Diego, CA -- (SBWIRE) -- 06/06/2022 -- Verrica Pharmaceuticals Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

24 Stocks Moving in Thursday's Pre-Market Session ↗

June 02, 2022

Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) rose 42.2% to $2.63 in pre-market trading after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an...

Via Benzinga

Analyst Ratings for Verrica Pharmaceuticals ↗

May 31, 2022

Within the last quarter, Verrica Pharmaceuticals (NASDAQ:VRCA) has observed the following analyst ratings:

Via Benzinga

RBC Capital Slashes Verrica's Price Target After Third Rejection - What's Next? ↗

May 25, 2022

Via Benzinga

Why Is Verrica Pharmaceuticals (VRCA) Stock Plunging 55% Today? ↗

May 25, 2022

VRCA stock is sinking over 50% in morning trading after the FDA declined to approve the company's treatment for "a viral skin disease."

Via InvestorPlace

69 Biggest Movers From Friday ↗

June 06, 2022

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates ↗

May 31, 2022

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,...

Via Benzinga

VERRICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Verrica Pharmaceuticals, Inc. on Behalf of Verrica Stockholders and Encourages Investors to Contact the Firm

May 30, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More ↗

May 30, 2022

Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for...

Via Benzinga

VERRICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Verrica Pharmaceuticals, Inc. on Behalf of Verrica Stockholders and Encourages Investors to Contact the Firm

May 29, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Verrica Pharmaceuticals Inc. (VRCA) Investors

May 27, 2022

From Kirby McInerney LLP

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

May 26, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

May 26, 2022

On Thursday, 94 companies set new 52-week lows.

Via Benzinga

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

May 26, 2022

From Law Offices of Howard G. Smith

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 26, 2022

Via Benzinga

20 Stocks Moving in Thursday's Pre-Market Session ↗

May 26, 2022

Gainers TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares rose 51.2% to $0.9603 in pre-market trading after dipping 18% on Wednesday.

Via Benzinga

The Law Offices of Frank R. Cruz Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

May 25, 2022

From Law Offices of Frank R. Cruz

Via Business Wire

88 Biggest Movers From Yesterday ↗

May 26, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...

Via Benzinga

6 Stocks Halted In Wednesday's Session: Here's Why ↗

May 25, 2022

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and...

Via Benzinga

Mid-Afternoon Market Update: Dow Rises Over 100 Points; Verrica Pharmaceuticals Shares Slide ↗

May 25, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 100 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 25, 2022

Via Benzinga

Mid-Day Market Update: Gold Drops Over 1%; StoneMor Shares Jump ↗

May 25, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 80 points on Wednesday.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 25, 2022

On Wednesday, 215 companies set new 52-week lows.

Via Benzinga

Mid-Morning Market Update: Markets Rise; Nasdaq Gains 100 Points ↗

May 25, 2022

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Wednesday.

Via Benzinga

Express (EXPR) Stock Pops 9% After Better-Than-Expected Q1 Earnings ↗

May 25, 2022

Express (EXPR) stock is rising higher on Wednesday after the fashion retailer reported results for the first quarter of 2022.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022 ↗

May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of...

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

May 25, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) gained 178.3% to $0.3762 as the company announced it increased retail distribution across Canada with Loblaw Companies.

Via Benzinga

Why Is Dick’s Sporting Goods (DKS) Stock Down 6% Today? ↗

May 25, 2022

Dick's Sporting Goods (DKS) stock is taking a beating on Wednesday after the retailer released its earnings report for Q1 2022.

Via InvestorPlace

The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine ↗

May 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Verrica Pharmaceuticals Inc. - Common Stock (NQ:VRCA)

All News about Verrica Pharmaceuticals Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today